2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow GPI-0100: new trials by email Literature Review of GPI-0100 trials Research Report on GPI-0100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer EC90 (KLH-FITC), GPI-0100, EC17 (Folate-FITC) - Cancer | Phase 1 | Completed | Endocyte | 13 | 2005-09-01 | 2012-03-09 |
| Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer GPI-0100, MUC-2-Globo H-KLH conjugate vaccine - Prostate Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 34 | 2000-07-01 | 2013-03-19 |
Neoplasms (1) · Prostatic Neoplasms (1) · Recurrence (1)
Endocyte (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2)
Richard A Messmann, MD, MHS, BSc (1) · Susan Slovin, MD, PhD (1)
P30CA008748 (1)